Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Human pluripotent stem cells: an emerging model in developmental biology.

Zhu Z, Huangfu D.

Development. 2013 Feb;140(4):705-17. doi: 10.1242/dev.086165. Review.

2.

Discovery of a Novel Polymer for Human Pluripotent Stem Cell Expansion and Multilineage Differentiation.

Celiz AD, Smith JG, Patel AK, Hook AL, Rajamohan D, George VT, Flatt L, Patel MJ, Epa VC, Singh T, Langer R, Anderson DG, Allen ND, Hay DC, Winkler DA, Barrett DA, Davies MC, Young LE, Denning C, Alexander MR.

Adv Mater. 2015 Jul 15;27(27):4006-12. doi: 10.1002/adma.201501351. Epub 2015 Jun 1.

3.

Directed differentiation of pluripotent stem cells: from developmental biology to therapeutic applications.

Irion S, Nostro MC, Kattman SJ, Keller GM.

Cold Spring Harb Symp Quant Biol. 2008;73:101-10. doi: 10.1101/sqb.2008.73.065. Epub 2009 Mar 27. Review.

PMID:
19329573
4.

Mechanobiology: a new frontier for human pluripotent stem cells.

Sun Y, Fu J.

Integr Biol (Camb). 2013 Mar;5(3):450-7. doi: 10.1039/c2ib20256e. Review.

5.

Adapting human pluripotent stem cells to high-throughput and high-content screening.

Desbordes SC, Studer L.

Nat Protoc. 2013 Jan;8(1):111-30. doi: 10.1038/nprot.2012.139. Epub 2012 Dec 20.

PMID:
23257981
6.

The advancement of human pluripotent stem cell-derived therapies into the clinic.

Thies RS, Murry CE.

Development. 2015 Sep 15;142(18):3077-84. doi: 10.1242/dev.126482. Erratum in: Development. 2015 Oct 15;142(20):3614.

7.

Gene targeting in human pluripotent stem cells.

Liu Y, Rao M.

Methods Mol Biol. 2011;767:355-67. doi: 10.1007/978-1-61779-201-4_26.

PMID:
21822888
8.

Exploiting pluripotent stem cell technology for drug discovery, screening, safety, and toxicology assessments.

McGivern JV, Ebert AD.

Adv Drug Deliv Rev. 2014 Apr;69-70:170-8. doi: 10.1016/j.addr.2013.11.012. Epub 2013 Dec 2. Review.

PMID:
24309014
9.

Systematic approaches to dissect biological processes in stem cells by image-based screening.

Erdmann G, Volz C, Boutros M.

Biotechnol J. 2012 Jun;7(6):768-78. doi: 10.1002/biot.201200117. Review.

PMID:
22653826
10.

Stable propagation of human embryonic and induced pluripotent stem cells on decellularized human substrates.

Abraham S, Sheridan SD, Miller B, Rao RR.

Biotechnol Prog. 2010 Jul-Aug;26(4):1126-34. doi: 10.1002/btpr.412.

PMID:
20730767
11.

Advances in culture and manipulation of human pluripotent stem cells.

Qian X, Villa-Diaz LG, Krebsbach PH.

J Dent Res. 2013 Nov;92(11):956-62. doi: 10.1177/0022034513501286. Epub 2013 Aug 9.

12.

Engineering the human pluripotent stem cell microenvironment to direct cell fate.

Hazeltine LB, Selekman JA, Palecek SP.

Biotechnol Adv. 2013 Nov 15;31(7):1002-19. doi: 10.1016/j.biotechadv.2013.03.002. Epub 2013 Mar 17. Review.

13.

Defining the nature of human pluripotent stem cell progeny.

Patterson M, Chan DN, Ha I, Case D, Cui Y, Van Handel B, Mikkola HK, Lowry WE.

Cell Res. 2012 Jan;22(1):178-93. doi: 10.1038/cr.2011.133. Epub 2011 Aug 16.

14.
15.

Generating cells of the gastrointestinal system: current approaches and applications for the differentiation of human pluripotent stem cells.

Wang A, Sander M.

J Mol Med (Berl). 2012 Jul;90(7):763-71. doi: 10.1007/s00109-012-0923-y. Epub 2012 Jun 20. Review.

PMID:
22714642
16.

Interspecific in vitro assay for the chimera-forming ability of human pluripotent stem cells.

Masaki H, Kato-Itoh M, Umino A, Sato H, Hamanaka S, Kobayashi T, Yamaguchi T, Nishimura K, Ohtaka M, Nakanishi M, Nakauchi H.

Development. 2015 Sep 15;142(18):3222-30. doi: 10.1242/dev.124016. Epub 2015 May 28.

17.

OLIG gene targeting in human pluripotent stem cells for motor neuron and oligodendrocyte differentiation.

Liu Y, Jiang P, Deng W.

Nat Protoc. 2011 May;6(5):640-55. doi: 10.1038/nprot.2011.310. Epub 2011 Apr 21.

PMID:
21527921
18.

Cluster characterization of mouse embryonic stem cell-derived pluripotent embryoid bodies in four distinct developmental stages.

Qin J, Guo X, Cui GH, Zhou YC, Zhou DR, Tang AF, Yu ZD, Gui YT, Cai ZM.

Biologicals. 2009 Aug;37(4):235-44. doi: 10.1016/j.biologicals.2009.03.001. Epub 2009 Mar 31.

PMID:
19339198
19.

The safety of human pluripotent stem cells in clinical treatment.

Simonson OE, Domogatskaya A, Volchkov P, Rodin S.

Ann Med. 2015;47(5):370-80. doi: 10.3109/07853890.2015.1051579. Epub 2015 Jul 6. Review.

PMID:
26140342
20.

Hepatic differentiation of human pluripotent stem cells on human liver progenitor HepaRG-derived acellular matrix.

Kanninen LK, Porola P, Niklander J, Malinen MM, Corlu A, Guguen-Guillouzo C, Urtti A, Yliperttula ML, Lou YR.

Exp Cell Res. 2016 Feb 15;341(2):207-17. doi: 10.1016/j.yexcr.2016.02.006. Epub 2016 Feb 8.

PMID:
26854693

Supplemental Content

Support Center